AGER and diabetes mellitus: The rationale for blockade of RAGE signal transduction is supported by work in a variety of preclinical disease models such as diabetes and its complications, Alzheimer’s disease53, 54, cardiovascular disease42, 44, 55, 56, immune/inflammatory disorders57, 58 and cancer59, 60, as examples.